Smith & Nephew Files Routine 6-K with SEC

Ticker: SNNUF · Form: 6-K · Filed: Mar 14, 2024 · CIK: 845982

Smith & Nephew PLC 6-K Filing Summary
FieldDetail
CompanySmith & Nephew PLC (SNNUF)
Form Type6-K
Filed DateMar 14, 2024
Risk Levellow
Pages6
Reading Time7 min
Key Dollar Amounts$5.5 billion
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 6-K, disclosure

Related Tickers: SNN

TL;DR

SNN files routine 6-K, no major news, just compliance.

AI Summary

Smith & Nephew plc filed a Form 6-K on March 14, 2024, to report information as a foreign private issuer. The filing does not contain specific financial figures or significant operational updates but serves as a routine disclosure to the SEC.

Why It Matters

This filing indicates Smith & Nephew is fulfilling its ongoing disclosure obligations as a foreign private issuer, ensuring transparency for investors.

Risk Assessment

Risk Level: low — This is a routine administrative filing with no new material financial or operational information that would typically impact risk.

Key Players & Entities

  • SMITH & NEPHEW PLC (company) — Registrant
  • 0000950103-24-003803 (filing_id) — Accession Number
  • March 14, 2024 (date) — Filing Date

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers required to furnish information to the SEC that they have made or are required to make public in their home country, or that they have distributed or are required to distribute to their security holders.

What is the filing date of this Form 6-K?

The filing date of this Form 6-K is March 14, 2024.

Is Smith & Nephew plc filing an annual report with this Form 6-K?

No, Smith & Nephew plc is filing a Form 6-K, which is a report of foreign private issuers, and indicates it files annual reports under Form 20-F.

What is the principal executive office address for Smith & Nephew plc?

The principal executive offices are located at Building 5, Croxley Park, Hatters Lane, Watford, Hertfordshire, WD18 8YE, England.

Does this filing contain specific financial results or operational updates?

Based on the provided text, this Form 6-K appears to be a routine disclosure and does not contain specific financial figures or operational updates.

Filing Stats: 1,734 words · 7 min read · ~6 pages · Grade level 15.9 · Accepted 2024-03-14 06:16:37

Key Financial Figures

  • $5.5 billion — ountries, and generated annual sales of $5.5 billion in 2023. Smith+Nephew is a constituent

Filing Documents

Forward-looking statements

Forward-looking statements This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading profit margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the in the markets we serve, especially those affecting health care providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers; competition for qualified personnel; strategic actions, including acquisitions and dispositions, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; relationships with healthcare professionals; reliance on information technology and cybersecurity; and numerous other matters that affect us or our markets, incl

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Smith & Nephew Plc (Registrant) Date: March 14, 2024 By: /s/ Helen Barraclough Helen Barraclough Company Secretary

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.